Nuclear Medicine: Page 94

Navidea signs distributor for India

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals has inked an exclusive licensing and distribution agreement with Sayre Therapeutics of Bangalore, India.

June 19, 2017

CereScan shows updated CereMetrix at SNMMI 2017

By AuntMinnie.com staff writers

Neurodiagnostic firm CereScan showcased new features on its CereMetrix database at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 18, 2017

Cerveau gets IND for tau imaging agent

By AuntMinnie.com staff writers

Radiopharmaceutical developer Cerveau Technologies said the U.S. Food and Drug Administration has given its MK-6240 tau imaging agent investigational new drug (IND) status.

June 18, 2017

SNMMI Image of the Year | Not so FAST for kids | Community breast MRI

By Brian Casey

June 14, 2017

ASNC releases guidance on MPI in women

By AuntMinnie.com staff writers

The American Society of Nuclear Cardiology (ASNC) has published an updated consensus statement on the use of stress myocardial perfusion imaging (MPI) in women. The statement includes recommendations for selecting the appropriate women for testing.

June 14, 2017

SNMMI: Education eases patients' nuclear medicine fears

By Wayne Forrest

DENVER - By providing basic educational materials on nuclear medicine and the potential risks from radiation exposure, clinicians can make patients feel more comfortable about their upcoming scans, according to a presentation on Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting.

June 14, 2017

SNMMI Image of the Year awarded to German researchers

By Wayne Forrest

DENVER - The Society of Nuclear Medicine and Molecular Imaging (SNMMI) on Wednesday awarded its Image of the Year to researchers who used PET/CT followed by fluorescence-guided surgery to demonstrate how dual-labeled prostate-specific membrane antigen (PSMA) inhibitors based on PSMA-11 enhance preoperative staging of metastatic prostate cancer.

June 14, 2017

SNMMI: PET/CT with prostate agent changes therapy plans

By AuntMinnie.com staff writers

Australian researchers found that treatment plans for more than half of prostate cancer patients were changed due to the results of PET/CT scans using a radiopharmaceutical that combines gallium-68 with a molecular compound that homes in on prostate-specific membrane antigen, according to a study presented at this week's Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting.

June 13, 2017

SNMMI taps new slate of officers for 2017-2018

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has announced a new slate of officers for the coming year at its annual meeting in Denver.

June 13, 2017

SNMMI: PET/ultrasound targets recurrent prostate cancer

By Wayne Forrest

DENVER - Researchers at Emory University are reporting early success in fusing fluciclovine-PET and 3D ultrasound images to better detect and biopsy suspected recurrent prostate cancer. They presented their findings at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting.

June 13, 2017

SNMMI: 2-for-1 PET detects dual Alzheimer's markers

By AuntMinnie.com staff writers

A PET protocol in which two scans are conducted after injection of one radiopharmaceutical holds the promise of detecting two clinical markers for Alzheimer's disease, according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting this week.

June 13, 2017

High amyloid levels on PET may indicate early Alzheimer's

By Kate Madden Yee

Elevated levels of amyloid on PET scans of the brain have been associated with an increased risk for Alzheimer's disease. But a study published June 13 in the Journal of the American Medical Association suggests that higher levels of amyloid could actually be the first preclinical sign of the illness.

June 13, 2017

Previous Page

Page 94 of 440

Next Page